New England Journal of Medicine · 1981 · 360 citations · 10 references
MedicineNephrologyPathologyImmunopathologyRenal PathologyRenal PathophysiologyGlomerular PathophysiologyRenal DiseaseRenal ImmunopathologyRenal ToxicityTransplant PharmacologyTransplant RejectionBlood Urea Nitrogen To Creatinine RatioBone Marrow Transplantation PathologyGraft-versus-host Disease PathophysiologyImmunosuppression ToxicityImmunosuppressive CompoundsTubular DegenerationTubular Toxicity
CYCLOSPORIN A, a fungal metabolite, is a potent new immunosuppressive drug1 , 2 that has been reported to prevent or ameliorate rejection of kidney and liver allografts3 4 5 and graft-versus-host disease after allogeneic marrow transplantation.6 , 7 A potentially harmful side effect of therapy with cyclosporin A is renal toxicity. Previous reports of nephrotoxicity after cyclosporin A have emphasized the mild and transient elevations of blood urea nitrogen (BUN) and creatinine.3 4 5 6 7 8 9 We now describe a distinct histologic constellation of glomerular thromboses and severe tubular damage, which correlated with the clinical course and laboratory findings of severe renal failure in three recipients of allogeneic marrow who . . .
10
Effects of the new anti-lymphocytic peptide cyclosporin A in animals.
J. F. Borel, Camille Feurer, C. Magnée et al. · PubMed · 1977 · 711 citations
Liver Transplantation with Use of Cyclosporin a and Prednisone
Thomas E. Starzl, Göran B. Klintmalm, Kendrick A. Porter et al. · New England Journal of Medicine · 1981 · 494 citations
Medicine, Pharmacotherapy, Surgery +14